Perspective Therapeutics, Inc. (CATX)

NYSEAMERICAN: CATX · Real-Time Price · USD

12.19

+0.10 (0.83%)

At close: Nov 4, 2024, 4:00 PM

12.71

+0.52 (4.27%)

After-hours: Nov 4, 2024, 7:59 PM EST

Perspective Therapeutics Market Cap

Perspective Therapeutics has a market cap or net worth of $821.94 million as of November 4, 2024. Its market cap has increased by 939.12% in one year.

Market Cap

821.94M

Enterprise Value

532.95M

1-Year Change

939.12%

Ranking

#2629

Market Cap Chart

Since November 10, 2005, Perspective Therapeutics's market cap has increased from $49.80M to $821.94M, an increase of 1,550.49%. That is a compound annual growth rate of 15.91%.

Market Cap History

Date	Market Cap	% Change
Nov 1, 2024	815.20M	622.70%
Dec 29, 2023	112.80M	221.37%
Dec 30, 2022	35.10M	-36.18%
Dec 31, 2021	55.00M	39.95%
Dec 31, 2020	39.30M	-6.65%
Dec 31, 2019	42.10M	108.42%
Dec 31, 2018	20.20M	-8.18%
Dec 29, 2017	22.00M	-31.03%
Dec 30, 2016	31.90M	-38.18%
Dec 31, 2015	51.60M	-35.58%
Dec 31, 2014	80.10M	317.19%
Dec 31, 2013	19.20M	-28.89%
Dec 31, 2012	27.00M	41.36%
Dec 30, 2011	19.10M	-28.20%
Dec 31, 2010	26.60M	30.39%
Dec 31, 2009	20.40M	343.48%
Dec 31, 2008	4.60M	-90.09%
Dec 31, 2007	46.40M	-40.28%
Dec 29, 2006	77.70M	9.75%
Dec 30, 2005	70.80M	42.17%

View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Silence Therapeutics	827.39M
Dianthus Therapeutics	822.55M
Embecta	822.25M
EyePoint Pharmaceuticals	821.94M
Healthcare Services Group	817.20M
Sana Biotechnology	814.23M
Replimune Group	813.02M
Avanos Medical	807.54M

Market Cap Rankings